About: EMA

Brexit 07-02-2018

Italian pharma chief: Dutch EMA bid ‘may have misled’ the Commission

The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.
Brexit 30-01-2018

Italy cries foul over temporary accommodation of EU Medicines Agency

Dutch officials and the head of the European Medicines Agency (EMA) sought yesterday (29 January) to allay any jitters among the agency's 900 London-based staff who are being asked to move to Amsterdam because of Britain's departure from the EU.
Health 12-01-2018

Stakeholders call for more transparent meetings between pharma and EMA

Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the continent’s healthcare industry, should be more transparent.
Health 14-12-2017

Access to clinical trials and innovative treatments at risk after Brexit

LONDON: Patients in Britain risk delays to access life-saving medicines if the UK deviates from EU regulatory standards post-Brexit, a leading medical representative has warned.
Brexit 21-11-2017

Paris celebrates the arrival of the European Banking Authority

At the end of a suspenseful day, delegates from 27 EU governments meeting in the General Affairs Council chose to relocate the European Medicines Agency to Amsterdam and the European Banking Authority to Paris. EURACTIV France reports.
Brexit 20-11-2017

Amsterdam, Paris take EU agencies in lucky dip thriller

Amsterdam and Paris won the right to host the two EU agencies that must leave London on Brexit after a dramatic ministerial meeting in Brussels on Monday (20 November) that left both result decided by drawing lots after votes were tied.
Brexit 10-11-2017

Fate of banking, medicines agencies to be decided by secret ballot

EU ministers will vote by secret ballot on the relocation of two EU agencies currently based in London at the General Affairs Council on 20 November. The ballot papers will then be destroyed and no record kept.
Health 10-11-2017

EMA relocation should consider the wellbeing of all Europeans

The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in order, writes Sandro Gozi.
Health 28-09-2017

Croatia minister on EMA: ‘Moral’ obligation to favour a country without EU agency

In assessing the relocation of the EU drugs agency EMA, old member states have a "moral and political obligation" to give an advantage to those candidate countries that do not currently host another EU agency, Croatia’s health minister told EURACTIV.com.
Health 14-09-2017

Greek minister: EMA bid shows drugs are a social good

Athens’ decision to claim the European Medicine Agency's relocation from London sends a message that medicine is “not just a commodity but a social good”, Greece’s Alternate Minister of Foreign Affairs, Georgios Katrougalos, told EURACTIV.com.
Health 02-08-2017

EU drug agency announces ‘business continuity’ plan amid relocation uncertainty

The European Medicines Agency (EMA) presented on Tuesday (1 August) a business continuity plan aimed at tackling the potential challenges poised by its relocation from London to another member state after the Brexit decision.
Brexit 01-08-2017

EU states compete to host London-based agencies after Brexit

All but six European Union states are bidding to host one or both the London-based EU agencies that will be relocated after Brexit, setting up a competition that could easily escalate into a squabble.